Breast cancer tumor tissue

Show results for

Unknown (5006)
Transcriptomics (2580)
Genomics (1138)
Proteomics (319)
Metabolomics (37)
Clinical (30)
Other (20)
Methylation profiling (18)
Genomic (15)
Models (4)
Multiomics (1)

Organisms

Homo sapiens (2301)
Mus musculus (808)
Rattus norvegicus (48)
Drosophila melanogaster (13)
Bos taurus (10)
Gallus gallus (10)
Sus scrofa (10)
Canis lupus familiaris (10)
Danio rerio (8)
Arabidopsis thaliana (4)
Capra hircus (3)
Heterocephalus glaber (3)
Ambystoma mexicanum (2)
Pan paniscus (2)
Helicobacter pylori (2)
Salmo salar (2)
Ovis aries (2)
Mus (2)
Veillonella parvula DSM 2008 (1)
Vitis labrusca x Vitis vinifera (1)
Larix kaempferi (1)
Haemophilus influenzae R2866 (1)
Rhipicephalus microplus (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S (1)
Strongylocentrotus purpuratus (1)
Leishmania major (1)
Fragaria x ananassa (1)
Ciona intestinalis (1)
Mus musculus x Mus spretus (1)
Macaca mulatta (1)

Organisms

Homo sapiens (483)
Mus musculus (150)
Rattus norvegicus (8)
Canis lupus familiaris (3)
Fusobacterium nucleatum (1)
unidentified (1)
human metagenome (1)
Macaca mulatta (1)

Repository

biostudies-arrayexpress (2443)
ENA (763)
geo (411)
EGA (171)
pride (114)
PeptideAtlas (75)
MassIVE (60)
MetaboLights (36)
dbGaP (15)
jPOST (14)
iProX (13)
PanoramaPublic (7)
GPMDB (5)
ExpressionAtlas (3)
BioModels (3)
NODE (3)
Cell Collective (1)
MetabolomicsWorkbench (1)

Tissue

Breast (40)
Liver (6)
Brain (5)
Kidney (5)
Lymph node (5)
Lung (4)
Pancreas (4)
Adrenal gland (2)
Esophagus (2)
Ovary (2)
Prostate gland (2)
Stomach (2)
Testis (2)
Urinary bladder (2)
Uterine cervix (2)
Uterus (2)
Blood (2)
Colon (2)
Bile duct (1)
Bone (1)
Bone marrow (1)
Bone tissue (1)
Caecum (1)
Cartilage tissue (1)
Chordate pharynx (1)
Connective tissue (1)
Gall bladder (1)
Hematopoietic system (1)
Ileum (1)
Large intestine (1)

Disease

Breast adenocarcinoma (6)
Breast carcinoma (6)
Lung adenocarcinoma (3)
Melanoma (3)
Neuroblastoma (3)
Non-small cell lung carcinoma (3)
Acute lymphoblastic leukemia (2)
Acute myeloid leukemia (2)
Cervical carcinoma (2)
Cervical squamous cell carcinoma (2)
Chondrosarcoma (2)
Chronic myelogenous leukemia (2)
Diffuse large B-cell lymphoma (2)
Gastric adenocarcinoma (2)
Glioma (2)
Hepatocellular carcinoma (2)
Large cell lung carcinoma (2)
Lung carcinoma (2)
Lymphoma (2)
Mesothelioma (2)
Multiple myeloma (2)
Osteosarcoma (2)
Ovarian adenocarcinoma (2)
Ovarian carcinoma (2)
Pancreatic adenocarcinoma (2)
Pancreatic carcinoma (2)
Plasmacytoma (2)
Prostate adenocarcinoma (2)
Renal cell carcinoma (2)
Rhabdomyosarcoma (2)

Technology Type

Mass Spectrometry (114)
Shotgun proteomics (73)
Bottom-up proteomics (20)
Mass spectrometry (14)
Mass spectrometry assay (14)
Data-dependent acquisition (12)
NMR spectroscopy (8)
SWATH MS (7)
Data-independent acquisition (6)
Mass spectrometry imaging (4)
454 GS FLX Titanium, Illumina HiSeq 2000 (1)
Affymetrix SNP 6.0, Illumina HT 12, Aperio image - H&E stained tissue_section (1)
Combined on identical nucleotide universal identifier, Illumina HumanWG-6 version 3 or Illumina HumanHT-12 expression bead chip (1)
Exiqon 7th generation miRCURY LNA microRNA microarray system (1)
ILLUMINA, Illumina HiSeq 2500 (1)
ILLUMINA, Illumina HiSeq 4000, Illumina HiSeq 2500 (1)
ILLUMINA, NextSeq 500 (1)
ILLUMINA, NextSeq 500, HiSeq X Ten (1)
Illumina HiSeq 2000, ILLUMINA, Illumina HiSeq 2500 (1)
Illumina HiSeq 2000, Illumina Genome Analyzer II (1)
Illumina HiSeq 2000, Illumina MiSeq (1)
Illumina HiSeq 2000, Illumina MiSeq, ILLUMINA, Illumina HiSeq 2500 (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2500, ILLUMINA (1)
Illumina HumanExome-12v1_A (1)
Illumina MiSeq (1)
Illumina MiSeq, Illumina HiSeq 2500, ILLUMINA (1)
IlluminaHuman HT12, IlluminaHuman AWG-6 and HT12 (1)
NextSeq 500, ILLUMINA (1)
NMR (1)

Instrument Platform

Illumina NovaSeq 6000 (105)
NextSeq 500 (54)
Illumina HiSeq 4000 (47)
Illumina HiSeq 2500 (41)
Illumina HiSeq 2000 (28)
NextSeq 550 (10)
Illumina NovaSeq X (8)
GenePix 4000B [Axon Instruments] (6)
10x Genomics Chromium Controller (5)
DNBSEQ-G400 (5)
Illumina MiSeq (5)
NextSeq 2000 (4)
HPC cluster Lobo (3)
Axon- GenePix4000B (3)
ScanArray 4000XL [PerkinElmer] (3)
Scanning hardware (3)
Axon Instruments GenePix 4000B scanner (2)
GeneChip Scanner 3000 7G (2)
Illumina Genome Analyzer IIx (2)
NA (2)
Illumina HiSeq 3000 (2)
DNBSEQ G40 (1)
TruSeq stranded Total RNA kit (1)
Using NEBNext Ultra II DNA Library (1)
D1000 ScreenTape Analysis, Qubit Fluorometer. (1)
MiRNeasy Serum/Plasma Advanced Kit (1)
DNA Genotek collection tubes (Ref CP-190) (1)
Maxwell RSC Instrument (1)
STAR v2.5.3a, rpkmforgenes, RSeQC 2.6.1 (1)
Illumina Nextera XT index kits (Set A–D) (1)

Publication Date

2015 (364)
2013 (300)
2010 (297)
2014 (273)
2011 (257)
2012 (250)
2016 (187)
2009 (139)
2008 (133)
2025 (108)
2024 (105)
2023 (102)
2021 (94)
2022 (90)
2026 (83)
2020 (76)
2019 (69)
2007 (60)
2017 (53)
2018 (52)
2006 (42)
2005 (30)
2004 (6)
2002 (4)

UNIPROT ID/AC

A0A024R8H9 (75)
A0A024RAN2 (75)
A0A024RC46 (75)
A0A087WT59 (75)
A0A087WTX5 (75)
A0A087WVW2 (75)
A0A087WWK8 (75)
A0A087WYL9 (75)
A0A087X130 (75)
A0A087X1V9 (75)
A0A0A0MR66 (75)
A0A0A0MS07 (75)
A0A0A0MS51 (75)
A0A0A0MSA7 (75)
A0A0C4DG89 (75)
A0A0C4DGT3 (75)
A0AVT1 (75)
A0FGR8 (75)
A0FGR8-2 (75)
A0FGR8-6 (75)
A0MZ66 (75)
A1L020 (75)
A1L170 (75)
A1X283 (75)
A2BFH1 (75)
A2NUT2 (75)
A3KN83 (75)
A4F255 (75)
A5A3E0 (75)
A5YKK6 (75)

ENSEMBL ID

ENSG00000147251 (75)
ENSG00000204131 (74)
ENSG00000229353 (74)
ENSG00000170477 (73)
ENSG00000247315 (45)
ENSG00000176092 (34)

CHEBI ID

CHEBI:15428 (8)
CHEBI:32816 (8)
CHEBI:16449 (6)
CHEBI:16919 (6)
CHEBI:18132 (6)
CHEBI:28300 (6)
CHEBI:15741 (5)
CHEBI:16870 (5)
CHEBI:18186 (5)
CHEBI:25017 (5)
CHEBI:78320 (5)
CHEBI:15354 (4)
CHEBI:15676 (4)
CHEBI:15891 (4)
CHEBI:16811 (4)
CHEBI:17053 (4)
CHEBI:17154 (4)
CHEBI:17191 (4)
CHEBI:17234 (4)
CHEBI:17368 (4)
CHEBI:17750 (4)
CHEBI:26271 (4)
CHEBI:26806 (4)
CHEBI:27266 (4)
CHEBI:27897 (4)
CHEBI:30832 (4)
CHEBI:30915 (4)
CHEBI:37024 (4)
CHEBI:7916 (4)
CHEBI:1148 (3)

Metabolite Name

Glycine (11)
Alanine (7)
Choline (7)
Creatine (7)
Glycerophosphocholine (7)
Myo-Inositol (7)
Pyridoxine (7)
Tyrosine (7)
Betaine (6)
Leucine (6)
Methionine (6)
Niacinamide (6)
Pyridoxal (6)
Pyruvate (6)
Allantoin (5)
Glucose (5)
Glutamine (5)
Histidine (5)
Hypoxanthine (5)
Isoleucine (5)
L-Serine (5)
Lactate (5)
Proline (5)
Sarcosine (5)
Succinate (5)
Valine (5)
7-methylguanosine (4)
ADP (4)
ATP (4)
Biotin (4)

First Public Date

2014 (166)
2024 (81)
2026 (74)
2025 (70)
2022 (60)
2023 (53)
2015 (45)
2021 (43)
2020 (40)
2018 (36)
2019 (34)
2017 (26)
2016 (21)
2013 (14)

Modelling Approach

Mathematical model (1)
Ordinary differential equation model (1)

Study status

Completed (13)
Recruiting (11)
Terminated (3)
Not provided (1)
Not yet recruiting (1)
Withdrawn (1)

Lab affiliation

University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (7)
Masaryk University, Faculty of Science (3)
Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill,NC 27599,USA (2)
European Institute of Oncology (2)
European Institute of Oncology, Milan (2)
Genetics Department, Federal University of Parana, Curitiba, Brazil (2)
Massachusetts Institute of Technology (2)
Tufts University (2)
Washington State University (2)
1. Division of Experimental Medicine, McGill University, Montreal, QC 2. Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC 3. Department of Pathology, Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC 4. Segal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC 5. Department of Oncology, McGill University, Montreal, QC (1)
1.Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada 2.Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, Quebec (1)
1Department of Pathology; University of California San Diego; La Jolla, CA 92093; USA (1)
AmsterdamUMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, The Netherlands (1)
Applied Bioinformatics of Cancer University of Edinburgh Cancer Research Centre Institute of Genetics and Molecular Medicine Edinburgh, United Kingdom (1)
Associate Professor of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN (1)
Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), Copenhagen, Denmark (1)
Breast Cancer Clinical Research Unit Centro Nacional de Investigaciones Oncológicas – CNIO Madrid, Spain. (1)
Breast Tumor Center Sun Yat-Sen Memorial Hospital Sun Yat-Sen University 107 Yanjiang West Road Guangzhou 510120, P.R.China (1)
BriaCell Therapeutics Corporation, Berkeley, CA, USA (1)
Cancer Metabolism and Tumor Microenvironment Group, Laboratory of Tumor and Development Biology, GIGA-Cancer, GIGA institute, University of Liege, Liege, Belgium (1)
Center for Scientific Research and Higher Education of Ensenada (CICESE) (1)
Centre for Cancer Biomarkers (CCBIO), Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Norway (1)
Centre for Gene Regulation and Expression University of Dundee (1)
Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Univer-sidade de Lisboa, Portugal (1)
Charles E. Foulds, Ph.D. Assistant Professor Lester and Sue Smith Breast Center Baylor College of Medicine (1)
Chemical & Biomolecular Engineering, Johns Hopkins University (1)
Clinical Research Division, Fred Hutchinson Cancer Reseaarch Center (1)
DZNE Munich Neuroproteomics, Feodor-Lynen-Str. 17, 81377 München, Germany (1)
Departmemt of Digital Medicine, University of Ulsan, College of Medicine, Asan Medical Center, South Korea (1)
Department of Biochemistry and Molecular and Structural Biology, Jozef Stefen Institute, Jamova cesta 39, 1000, Ljubljana, Slovenia (1)

Keyword

Recurrent breast cancer (6)
Recurrent colon cancer (6)
Stage IV breast cancer (6)
Stage IV colon cancer (6)
Stage IV pancreatic cancer (5)
Recurrent pancreatic cancer (4)
Stage II pancreatic cancer (4)
Stage III colon cancer (4)
Stage III pancreatic cancer (4)
Stage IIIA breast cancer (4)
Stage IIIB breast cancer (4)
Stage IIIC breast cancer (4)
Adult primary hepatocellular carcinoma (3)
Advanced adult primary liver cancer (3)
Recurrent adult primary liver cancer (3)
Recurrent melanoma (3)
Recurrent non-small cell lung cancer (3)
Recurrent ovarian epithelial cancer (3)
Recurrent rectal cancer (3)
Stage IV melanoma (3)
Stage IV non-small cell lung cancer (3)
Stage IV ovarian epithelial cancer (3)
Stage IV rectal cancer (3)
Cancer Stem Cells (2)
Cyclophosphamide (2)
Extensive stage small cell lung cancer (2)
Immunomodulating Agents (2)
Localized unresectable adult primary liver cancer (2)
Male breast cancer (2)
Recurrent adult soft tissue sarcoma (2)

IsPrivate

False (3)

Classification

bacteria (1)

Modification

N6 (2)
2x(15)N labeled L-lysine (1)
4x(15)N labeled L-arginine (1)
N6-dimethyl-L-lysine (1)

Study type

Transcription profiling by array (1492)
RNA-seq of coding RNA (224)
Comparative genomic hybridization by array (103)
RNA-seq of coding RNA from single cells (102)
ChIP-seq (90)
Methylation profiling by array (81)
Unknown experiment type (64)
RNA-seq of non coding RNA (31)
Proteomic profiling by array (28)
Methylation profiling by high throughput sequencing (25)
Other (23)
Genotyping by array (22)
MicroRNA profiling by array (21)
ChIP-chip by tiling array (18)
DNA-seq (17)
Transcription profiling by RT-PCR (14)
Human - High-throughput sequencing (11)
RNA-seq of total RNA (11)
ChIP-chip by array (9)
Animal - High-throughput sequencing (5)
Cell line - High-throughput sequencing (5)
ATAC-seq (5)
Animal - One-color microarray (3)
High-throughput sequencing (3)
RNAi profiling by array (3)
Differential (2)
One-color microarray (2)
Cell line - One-color microarray (2)
Human - One-color microarray (2)
Proteomic profiling by mass spectrometer (2)

Release Date

2016 (537)
2023 (528)
2021 (516)
2020 (493)
2022 (486)
2015 (472)
2024 (463)
2025 (459)
2014 (428)
2013 (382)
2010 (374)
2019 (352)
2018 (341)
2012 (337)
2011 (332)
2017 (315)
2009 (192)
2008 (160)
2026 (83)
2007 (74)
2006 (50)
2005 (43)
2004 (10)
2002 (10)
2003 (6)
2000 (3)
1999 (2)
2001 (1)

Location

United States (20)
Canada (5)
France (1)
Germany (1)
India (1)
Israel (1)
Italy (1)
Netherlands (1)
United Kingdom (1)

Previous page
1 / 918
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 918
Next page

Sort by:

Relevance

Page size

Historical Biobanks in Breast Cancer Metabolomics - Challenges and Opportunities

BACKGROUND: Metabolomic characterization of tumours can potentially improve prediction of cancer prognosis and treatment response. Here, we describe efforts to validate previous metabolomic findings using a historical cohort of breast cancer patients and discuss challenges with u...

2022-01-24 | MTBLS1355 | MetaboLights

Adipocyte-specific Zeb1 confers breast cancer progression by triggering the tumor-associated adipose microenvironment remodeling_Lipidomics_amino

Upon penetrating the basement membrane, breast cancer cells directly interact with their surrounding adipose tissue, which forms a unique tumor-associated adipose microenvironment (TAME). However, the underlying mechanism involved in the regulation of lipid metabolic remodeling in the TAME remain...

2025-04-30 | MTBLS12287 | MetaboLights

Adipocyte-specific Zeb1 confers breast cancer progression by triggering the tumor-associated adipose microenvironment remodeling

2025-04-30 | MTBLS12286 | MetaboLights

Adipocyte-specific Zeb1 confers breast cancer progression by triggering the tumor-associated adipose microenvironment remodeling

2025-04-30 | MTBLS12405 | MetaboLights

Adipocyte-specific Zeb1 confers breast cancer progression by triggering the tumor-associated adipose microenvironment remodeling_untargeted metabolites_Lipidomics

2025-04-30 | MTBLS12289 | MetaboLights

Adipocyte-specific Zeb1 confers breast cancer progression by triggering the tumor-associated adipose microenvironment remodeling_Medium and long chain fatty acids

2025-04-30 | MTBLS12290 | MetaboLights

Adipocyte-specific Zeb1 confers breast cancer progression by triggering the tumor-associated adipose microenvironment remodeling_Medium and long chain fatty acids_four group

2025-04-30 | MTBLS12291 | MetaboLights

Metabolic phenotyping of ex-vivo breast samples by DESI mass spectrometry imaging

This study involves the analysis of surgically resected samples from patients undergoing breast surgery. The samples published here have been used as part of the publication by [1], and all experimental details can be found within. Desorption electrospray ionisation mass spectrometry imaging (DESI M...

2016-04-28 | MTBLS273 | MetaboLights

1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients

1H NMR is used to detect alterations in metabolites and their linkage to metabolic processes in a number of pathological conditions including breast cancer. Inositol 1, 4, 5 trisphosphate (IP3R) receptor is an intracellular calcium channel known to regulate metabolism and cellular bioenergetics. Its...

2017-07-18 | MTBLS326 | MetaboLights

Organotypic microfluidic breast cancer model reveals starvation-induced spatial-temporal metabolic adaptations

BACKGROUND: Ductal carcinoma in situ (DCIS) is the earliest stage of breast cancer. During DCIS, tumor cells remain inside the mammary duct, growing under a microenvironment characterized by hypoxia, nutrient starvation, and waste product accumulation; this harsh microenvironment promotes genomic in...

2019-02-08 | MTBLS669 | MetaboLights

Previous page
1 / 918
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 918
Next page

Sort by:

Relevance

Page size

9174 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Study status

Lab affiliation

Tags

Keyword

IsPrivate

Classification

Modification

Study type

Release Date

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets